Paul Diaz is a Managing Partner at Cressey & Company responsible for identifying, consummating, and monitoring new investment partnerships as well as developing relationships with talented healthcare executives.

Before re-joining Cressey in 2025, Paul continued to serve as Partner Emeritus and a member of the Distinguished Executives Council. In 2020, Paul was named the President and CEO of Myriad Genetics, Inc., a genetic testing, and precision medicine company focused on accessing the risk of developing disease and guide treatment decisions. Prior to that, Paul was a partner with Cressey (2016-2020) before he served as the President and CEO of Kindred Healthcare (2002-2016), a Fortune 500 Company and one of the largest providers of healthcare services in the United States. 

Paul formerly held board of director positions at various public healthcare companies and remains active with not-for-profit organizations including Johns Hopkins Medicine and the Georgetown Law Center. And, through his deepen commitment and dedication to healthcare, he has previously been recognized through different publications, most notably, Modern Healthcare magazine, where Paul was named one of the 100 Most Influential People and one of the top 25 Minority Executives in Healthcare. Recently, Paul was recognized as one of the Top 25 Biotech Executives of 2024 by the Healthcare Technology Report. 

Paul earned his BS in Finance and Accounting from American University’s Kogod School of Business and a JD from the Georgetown University Law Center in Washington, D.C., and is a proud Eagle Scout.